BRCA2 and neoplasm: Indeed, in MMR-deficient tumors but not in MMR-proficient tumors, frameshift mutations in mononucleotide tracts have been identified in tumor suppressors and DNA repair genes such as BRCA1, BRCA2 and BLM80,81, and tumor progression genes such as BAX82 and TGFB283.